Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
2.420
0.00 (0.00%)
At close: Jul 14, 2026, 4:00 PM EDT
2.410
-0.010 (-0.41%)
After-hours: Jul 14, 2026, 7:42 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $6.94 million as of July 14, 2026. Its market cap has decreased by -66.19% in one year.
Market Cap
6.94M
Enterprise Value
4.40M
1-Year Change
-66.19%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $6.94M, a decrease of -88.07%. That is a compound annual growth rate of -45.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 6.94M | -56.21% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.23M |
| MetaVia | 9.19M |
| Quoin Pharmaceuticals | 8.94M |
| BioRestorative Therapies | 8.79M |
| Imunon | 8.49M |
| TransCode Therapeutics | 8.39M |
| Jupiter Neurosciences | 8.25M |
| Aspire Biopharma Holdings | 7.78M |